Cambridge researchers report that a temporary mRNA treatment encouraged damaged heart-muscle cells to divide in mice after a heart attack. The treatment activates two proteins, Myc and Cyclin T1, and was injected into the animals' hearts.

The university's November 9 account says treated mice pumped around 10% more blood with each beat than mice given a mock treatment. Reassessment after 28 days and 12 weeks found that the improvement persisted. The researchers reported no observed adverse effects in the study.

Those results do not establish safety or effectiveness in people. The team says larger-animal studies and then human trials are needed. The encouraging advance is narrower and concrete: a temporary, localized intervention promoted repair and improved measured heart function in an animal experiment. It gives researchers a result to build on, rather than a treatment patients can use today.

Source published November 9, 2026; animal-study results.

A University of Liverpool-led team reports a new mechanism in talin, a protein that helps cells attach to their surroundings and sense mechanical forces. When talin stretches, it can expose a region that allows talin molecules to bind to each other.

The work clarifies the role of a region long thought to be chiefly an attachment site for integrins. The researchers found that another protein, vinculin, can separate the talin assemblies again, adding a way to control the connection.

The study appears in Proceedings of the National Academy of Sciences. Liverpool's November 9 account describes molecular properties resembling those associated with amyloid formation, used here for a useful cellular function. That resemblance does not make this an Alzheimer's treatment. The good news is a clearer account of a basic biological mechanism: cells have another way to turn a physical pull into a controlled response.

Source published November 9, 2026.